IgG4-RD Specialty Account Manager — Remote Impact

Amgen Inc.; Oregon; Híbrido; USD 145.000 - 215.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Remote work possible

Bonus program

Long-term incentives

Benefits package

Descripción de la vacante

Amgen in the United States seeks an Account Manager/Specialty Account Manager to represent Amgen products to physicians and healthcare professionals, drive sales, and manage a total territory. You will deliver disease education and collaborate with cross-functional teams to support patient care and access.

The role requires building relationships with local and national KOLs, navigating a matrix organization, and using a consultative selling approach for IgG4-RD.

Formación

• Bachelor's degree and relevant sales experience required.
• Experience in pharmaceutical, biotech, or medical device sales.
• Ability to operate in a matrix environment and cross-functional teams.

Responsabilidades

• Represent Amgen products to physicians and healthcare professionals.
• Achieve sales objectives and execute strategic account plans.
• Develop relationships with local, regional, and national KOLs.
• Navigate healthcare landscape to identify opportunities and patient access considerations.
• Maintain in-depth disease and therapeutic knowledge for IgG4-RD.
• Adhere to compliance and reporting requirements.

Conocimientos

Sales experience in pharma/biotech

Excellent communication

Account management

Team collaboration

Educación

Bachelor's degree

Master's degree

Doctorate degree

Herramientas

Microsoft Office

Descripción del empleo

Amgen in the United States seeks an Account Manager/Specialty Account Manager to represent Amgen products to physicians and healthcare professionals, drive sales, and manage a total territory. You will deliver disease education and collaborate with cross-functional teams to support patient care and access.

The role requires building relationships with local and national KOLs, navigating a matrix organization, and using a consultative selling approach for IgG4-RD.